From 2018 which is interesting for those who are not up with the hstory of PTX-100 and 200. When SS references the results of the breast cancer trial, it is PTX-200. So, it'll be good to know if the AML trial results pique any interest as a farm out or as a combo drug given that switches of the AKT pathway in which leads to cancer growth. Things could get interesting if we get something out of left field!
PTX Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
